Mesoblast Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other companies in this sector in Australia: Factor Therapeutics Ltd (2017 sales of 3.07 million Australian Dollars [US$2.39 million] of which 100% was Biotechnology), Phylogica Limited (2.76 million Australian Dollars [US$2.15 million] ), and Starpharma Holdings Limited (3.65 million Australian Dollars [US$2.84 million] of which 100% was Dendritic).

Sales Analysis. Sales fell dramatically in 2017: During the year ended June of 2017, sales at Mesoblast Ltd were A$3.20 million (US$2.49 million). This is a sharp decrease of 94.5% versus 2016, when the company's sales were A$58.52 million.